VIVUS, Inc. (NASDAQ:VVUS) average recommendation is hold with average Target Price of $11.30. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $6.58 in last trading session, and closed at $6.53, trading in the range of $6.45 – $6.81. The stock showed a negative weekly performance of -11.99%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced that the company is scheduled to present a corporate overview at two upcoming investor conferences at The Waldorf Astoria in New York City: 16th Annual BIO CEO & Investor Conference Presentation: February 11, 2014, at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time) 2014 Leerink Global Healthcare Conference Presentation: February 12, 2014, at 1:50 p.m. Eastern Time (10:50 a.m. Pacific Time) Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares closed at $6.00 on last trade day, by gaining 3.27%. Stock 52 week range is $4.05 – $9.25. Company’s market capitalization is $1.31 billion.
Shares of Cell Therapeutics (NASDAQ:CTIC) were the recipient of some unusual options trading activity on Friday. Traders purchased 17,748 put options on the stock, StockRatingsNetwork reports. This is an increase of 199% compared to the typical daily volume of 5,945 put options. Cell Therapeutics Inc (NASDAQ:CTIC) stock advanced 17.67% and finished the last session at $3.33. The EPS of the stock remained -0.75. Company’s market capitalization is $486.80 billion.
Leave a Reply